Aims And Scope - Turkish Journal of Hematology
AIMS AND SCOPE
The Turkish Journal of Hematology is published quarterly (March, June, September, and December) by the Turkish Society of Hematology. It is an independent, non-profit peer-reviewed international English-language periodical encompassing subjects relevant to hematology.
Submissions of the manuscripts to TJH, evaluation of the manuscripts by the referees and publication stages are completely free of charge.
All publications of TJH can be accessed free of charge online at www.tjh.com.tr. Thus, it is possible for a wide audience to read your work.
The Editorial Board of The Turkish Journal of Hematology adheres to the principles of the
World Association of Medical Editors (WAME), International Council of Medical Journal Editors (ICMJE),
Committee on Publication Ethics (COPE),
Consolidated Standards of Reporting Trials (CONSORT) and
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE).
The aim of The Turkish Journal of Hematology is to publish original hematological research of the highest scientific quality and clinical relevance. Additionally, educational material, reviews on basic developments, editorial short notes, images in hematology, and letters from hematology specialists and clinicians covering their experience and comments on hematology and related medical fields as well as social subjects are published. As of December 2015, The Turkish Journal of Hematology does not accept case reports.
General practitioners interested in hematology and internal medicine specialists are among our target audience, and The Turkish Journal of Hematology aims to publish according to their needs. The Turkish Journal of Hematology is indexed, as follows:
2022 Impact Factor: 2.6
Digital Archiving and Preservation Policy
Digital preservation is a set of processes and activities that ensure the retrieval and distribution of information now available in digital formats to guarantee long-term, perpetual access. The preservation policy includes the following measures:
Website Archiving
All of the electronic content (website, manuscript, etc.) is stored in three different sources. Content on a server is online and accessible to readers. A copy of the same content is preserved as a backup on other servers. Should a server fail, other resources can be brought online, and the website is expected to be available in 24-36 hours.
Abstracting/Indexing Services
Our journal's Abstracting/Indexing services store essential information about articles. In addition, some of our journals’ Abstracting/Indexing services archive metadata about the article and electronic versions of the articles.In this way, copies of articles are presented to the scientific community through these systems as an alternative to journals. This journal’s archive has been backed up by PubMed Central as from 2012 publications.
Cessation of publication
If this journal must stop publishing, the articles will remain online and accessible to readers through third parties and archiving processes such as those described above. Content can be accessed through PORTICO when required under certain circumstances, such as when the collection is stopped.
Author Self-Archiving Policy
Abstract and Citation Information
Authors may reuse the Abstract and Citation information (e.g. Title, Author name, Publication dates) of their article anywhere at any time including social media such as Facebook, blogs and Twitter, providing that where possible a link is included back to the article on the Turkish Journal of Hematology website.
Accepted Manuscript
The Accepted Manuscript is the final draft author manuscript, as accepted for publication by a journal, including modifications based on referees’ suggestions, before it has undergone copyediting, typesetting and proof correction. This is sometimes referred to as the post-print version.
Authors of Open Access articles are free to post and distribute their links anywhere immediately upon publication.
Subscription Information
The Turkish Journal of Hematology is sent free-of-charge to members of Turkish Society of Hematology and libraries in Türkiye and abroad. Hematologists, other medical specialists that are interested in hematology, and academicians could subscribe for only 40 $ per
published issue. All published volumes are available in full text free-of-charge online at www.tjh.com.tr.
Address: Turan Güneş Bulv. İlkbahar Mah. Fahreddin Paşa Sokağı (eski 613. Sok.) No: 8 Çankaya - ANKARA, Türkiye
Telephone: +90 312 490 98 97
Fax: +90 312 490 98 68
Online Manuscript Submission:
https://mc.manuscriptcentral.com/tjh
Web page:
www.tjh.com.tr
E-mail:
[email protected]
Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. Open Access Policy is based on rules of Budapest Open Access Initiative (BOAI)
http://www.budapestopenaccessinitiative.org/. By “open access” to [peer-reviewed research literature], we mean its free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself. The only constraint on reproduction and distribution, and the only role for copyright in this domain, should be to give authors control over the integrity of their work and the right to be properly acknowledged and cited.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 (CC BY-NC-ND) International License.
CC BY-NC-ND: This license allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
CC BY-NC-ND includes the following elements:
BY – Credit must be given to the creator
NC – Only noncommercial uses of the work are permitted
ND – No derivatives or adaptations of the work are permitted
Permission Requests
Permission required for use any published under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 (CC BY-NC-ND) International License with commercial purposes (selling, etc.) to protect copyright owner and author rights). Republication and reproduction of images or tables in any published material should be done with proper citation of source providing authors’ names; article title; journal title; year (volume) and page of publication; copyright year of the article.”
Permissions
Requests for permission to reproduce published material should be sent to the editorial office.
Editor: Professor Dr. Reyhan Diz Küçükkaya
Adress: Turan Güneş Bulv. İlkbahar Mah. Fahreddin Paşa Sokağı (eski 613. Sok.) No: 8 Çankaya - ANKARA, Türkiye
Telephone: +90 312 490 98 97
Fax: +90 312 490 98 68
Online Manuscript Submission: http://mc.manuscriptcentral.com/tjh
Web page: www.tjh.com.tr
E-mail: [email protected]
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
Publisher
Galenos Yayinevi
Molla Gürani Mah. Kaçamak Sk. No:21 34093 Fındıkzade-İstanbul
Telephone : 0212 621 99 25
Fax : 0212 621 99 27
[email protected]
Instructions for Authors
Instructions for authors are published in the journal and at www.tjh.com.tr
Material Disclaimer
Authors are responsible for the manuscripts they publish in The Turkish Journal of Hematology. The editor, editorial board, and publisher do not accept any responsibility for published manuscripts.
If you use a table or figure (or some data in a table or figure) from another source, cite the source directly in the figure or table legend.
Editorial Policy
Following receipt of each manuscript, a checklist is completed by the Editorial Assistant. The Editorial Assistant checks that each manuscript contains all required components and adheres to the author guidelines, after which time it will be forwarded to the Editor in Chief. Following the Editor in Chief’s evaluation, each manuscript is forwarded to the Associate Editor, who in turn assigns reviewers. Generally, all manuscripts will be reviewed by at least three reviewers selected by the Associate Editor, based on their relevant expertise. Associate editor could be assigned as a reviewer along with the reviewers. After the reviewing process, all manuscripts are evaluated in the Editorial Board Meeting.
Turkish Journal of Hematology’s editor and Editorial Board members are active researchers. It is possible that they would desire to submit their manuscript to the Turkish Journal of Hematology. This may be creating a conflict of interest. These manuscripts will not be evaluated by the submitting editor(s). The review process will be managed and decisions made by editor-in-chief who will act independently. In some situation, this process will be overseen by an outside independent expert in reviewing submissions from editors.
Advertising Policy
The Turkish Journal of Hematology is the official journal of The Turkish Society of Hematology which is the financial supporter of the journal.
Advertising fees are transferred to The Turkish Society of Hematology, which are used for publishing expenses of the journal.
This journal's advertising sales and editorial processes are separated to ensure editorial independence and reduce the effects of financial interests.
Current or potential sponsors and advertisers do not affect editorial decisions in the journal. Advertisers and sponsors have no control or influence over the results of a user's website searches.
Advertisements should not be deceptive or misleading and must be verifiable. Excessive or exaggerated expressions does not be allowed.
If the text or image contains inappropriate or offensive content or is about personal, racial, ethnic, sexual orientation or religious content, these advertisements are not accepted.
Advertisers are responsible for ensuring that their advertisements comply with applicable laws regarding deceptive and/or offensive content and ethical issues.
Especially drug and medical product advertisements can be presented on the cover pages of the journal, separately from the published scientific content and without page number.
The published advertisements are pointed and distinguishable from the editorial content.
